logo
Top Stories
56
45
LaCroix-102317-lg.jpg

Nick Caporella, the chief executive officer of National Beverage Corp. (FIZZ), has lashed out at short sellers after his company's shares declined more than 22 percent this month from their September 11 peak. In a statement peppered with italicised...

Colcap, the main index of the Colombian Stock Exchange, fell 0.32% Monday, closing at 1,460.36 amid fears over the consequences of an expected interest rate hike in the United States. Ramses Pestanapalmett, an analyst at Ultraserfinco, said that a...

ShinzoAbe-102317-lg.jpg

Japanese Prime Minister Shinzo Abe has retained power with the ruling coalition winning a decisive two-thirds majority in parliament. This is Abe's third term as Prime Minister. Abe's Liberal Democratic Party and coalition partner Komeito together...

The Malaysia stock market picked up less than a point on Monday - but that was enough to snap the four-day slide in which it had fallen almost 15 points or 0.9 percent to a fresh six-month closing low. The Kuala Lumpur Composite Index remains just above...

JamesToback-102317-lg.jpg

The US media has come out with another story of sexual harassment involving a Hollywood big shot at a time the Harvey Weistein saga is hot in the air. The Los Angeles Times reported that 38 women have come forward to accuse Oscar-nominated director...

Pharma-101317.jpg The following are some of the biotech stocks that made their way onto the Day's Gainers & Losers' list of October 16, 2017.
Asianmarkets-112014_16Oct17.jpg Asian stock markets are mostly higher on Tuesday with modest gains, with the fresh record highs on Wall Street and firm commodity prices boosting investor sentiment. Comments by Federal Reserve Chair Janet Yellen, who reiterated her belief that additional gradual interest rate hikes are likely to be appropriate over the next few years, also supported stocks.
pharma-101717.jpg Today's Daily Dose brings you news about Restoration Robotics' closing of IPO; Immune Design's plans to initiate a pivotal phase 3 trial of CMB305 in patients with synovial sarcoma; Bristol-Myers' exploration of new indication for its blockbuster immunotherapy drug Opdivo and Fennec's SIOPEL 6 study results.
shareflat-101717.jpg European stocks look set to open largely unchanged on Tuesday as the stand-off over independence for Catalonia continued and North Korea warned that a nuclear war could "break out any moment." The dollar edged up against its peers, helped by a rise...
More
Trump-Smile-102017.jpg President Donald Trump has reportedly offered his support to three Republican Senators that former White House chief strategist Steve Bannon has indicated he would like to unseat. Citing five people familiar with the calls, a report from Politico said...
More
Patty-Murray-Lamar-102017.jpg Senate Health Committee Chairman Lamar Alexander, R-Tenn., and ranking member Patty Murray, D-Wash., announced Thursday that twenty-two other Senators are cosponsoring their bipartisan plan to provide short-term stability to Obamacare. The bipartisan...
More
Ukflag-Pound-102017.jpgThe UK budget posted the smallest budget deficit in a decade for the month of September, suggesting that the borrowing is on the course to undershoot the full-year target. Public sector net borrowing, excluding banks, decreased by GBP 0.7 billion from the previous year to GBP 5.9 billion in September, the Office for National Statistics said Friday.
More
The South Korea stock market has finished higher in back-to-back sessions, collecting almost 17 points or 0.7 percent along the way. The KOSPI now rests just above the 2,490-point plateau although it may run out of steam on Tuesday. The global forecast for the Asian markets suggests mild consolidation,...
Hasbro-102317.jpg
Play and entertainment company Hasbro, Inc. reported Monday higher profit in its third quarter, benefited by strong revenues in all regions. Both earnings and topline beat market estimates. The improvements were partly offset by negative impact of the Toys"R"Us bankruptcy in the U.S. and Canada. Looking ahead, the company projects higher revenues for the fourth quarter.
More
The bench to bedside journey of drugs is fraught with challenges. It is estimated that only 5 in 5,000 compounds that enter preclinical testing make it to human testing, and out of those 5, only 1 may pass through all the regulatory hurdles needed to reach pharmacy shelves. More
AstraZeneca (AZN, AZN.L) and Merck & Co., Inc. (MRK) said that they have submitted a new drug application to Japan's Pharmaceuticals and Medical Devices Agency or PMDA for the use of Lynparza or olaparib tablets in unresectable or recurrent BRCA-mutated... More
Japanese Prime Minister Shinzo Abe has promised to take a firm stance on North Korea, after a predicted landslide win in Sunday's parliamentary elections. Abe had called the snap vote to seek a boost to his parliamentary majority and is likely to use...
More
Follow RTT
Economic Calendar
DateIndicatorPeriodCountry
10/23/17 10:30CB Coincidence IndexAUG Australia
10/23/17 10:30CB Leading IndexAUG Australia
10/23/17 10:0Consumer Confidence IndexOCT P Eurozone
10/23/17 8:30Wholesale Sales (M-o-M)SEP Canada
10/23/17 8:30Wholesale Sales (Y-o-Y)AUG Canada
10/23/17 8:0M3 Money Supply (M-o-M)SEP Poland
Complete Economic Calendar
FDA Calendar
Event DateSymbolDrug NameEvent Name
01/12/18LGNDLUXTURNA (BLA)FDA decision on LUXTURNA for inherited retinal disease
01/12/18ONCELUXTURNA (BLA)FDA decision on LUXTURNA for treatment of patients with vision loss due to confirmed biallelic RPE65 mutation-associated retinal dystrophy.
01/10/18LLYAbemaciclib (NDA)FDA decision on Abemaciclib for the treatment of advanced breast cancer
01/07/18XENTSINUVA implant (NDA)FDA decision on SINUVA implant for patients with recurrent ethmoid sinus obstruction
12/30/17AEZ.TO, AEZSMacrilen (NDA resubmission)FDA decision on Macrilen for the evaluation of growth hormone deficiency in adults
Complete FDA Calendar